Single Shot Intrathecal Ziconotide for Painful Neuropathy or Myelopathy

Summary

This is a phase 4 study being conducted at the Ohio State University Department of Neurology Multiple Sclerosis Research Program. The purpose of the study is to administer a single shot of intrathecal (injection into the space surrounding the spinal cord via a lumbar puncture or spinal tap) ziconotide as a test dose to patients who have chronic painful myelopathy (pain from spinal cord damage) or painful peripheral neuropathy (pain from nerve damage) that has not responded to other pain medicines.

Timeline

Start

2014-01

Primary completion

2015-12

Completion

2015-12

Outcome

Outcome not reported

Stopped (Enrollment): “Logistical issues with study process and recruitment”

Drugs

Indications